Arcus Biosciences Reports Fourth-Quarter and Full-Year 2022 Financial Results and Provides a Pipeline Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. DFTX
6. GOOGL
7. APGE
8. MU
9. HOOD
10. IBM

Go back to Arcus Biosciences Reports Fourth-Quarter and Full-Year 2022 Financial Results and Provides a Pipeline Update

Arcus Biosciences (RCUS) Tops Q4 EPS by 22c

February 28, 2023 4:38 PM EST

Arcus Biosciences (NYSE: RCUS) reported Q4 EPS of ($0.93), $0.22 better than the analyst estimate of ($1.15). Revenue for the quarter came in at $34 million versus the consensus estimate of $22.59 million.

For earnings history and earnings-related data on Arcus Biosciences (RCUS) click here.

... More